Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients-Reference-Cited by-同舟云学术

Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients

Author:

Nischwitz S.¹,Faber H.¹,Sämann P. G.²,Domingues H. S.³⁴,Krishnamoorthy G.³,Knop M.¹,Müller-Sarnowski F.¹,Yassouridis A.⁵,Weber F.¹

Affiliation:

1. RG Inflammatory Disorders of the CNS, Neurology; Max Planck Institute of Psychiatry; Munich Germany

2. RG Neuroimaging; Max Planck Institute of Psychiatry; Munich Germany

3. Max Planck Institute of Neurobiology; Martinsried Germany

4. Instituto de Biologia Molecular e Celular R. Campo Alegre; Porto Portugal

5. RG Biostatistics; Max Planck Institute of Psychiatry; Munich Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

Reference29 articles.

1. Multiple sclerosis;Compston;Lancet,2008

3. Interleukin- 16;Cruikshank;J Leukoc Biol,2000

4. Processing and release of IL-16 from CD4+ but not CD8+ T-cells is activation dependent;Wu;J Immunol,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献